0.52  0 (0%)		10-24 14:09
Open: 0.52 High: 0.52 Volume: 700		Pre. Close: 0.52 Low: 0.52 Market Cap: 1(M)

Short term
Mid term
Targets	6-month :	0.92	1-year :	1.16
Resists	First :	0.79	Second :	0.99
Pivot price	0.6
Supports	First :	0.46	Second :	0.38
MAs	MA(5) :	0.52	MA(20) :	0.63
	MA(100) :	2.21	MA(250) :	5.47
MACD	MACD :	-0.3	Signal :	-0.3
%K %D	K(14,3) :	20.3	D(3) :	17.3
RSI	RSI(14): 33.8
52-week	High :	36	Low :	0.46

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ XAGE ] has closed above bottom band by 25.7%. Bollinger Bands are 79.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.58 - 0.58	0.58 - 0.58
Low:	0.51 - 0.51	0.51 - 0.51
Close:	0.51 - 0.51	0.51 - 0.52

Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Mon, 15 Sep 2025
Longevity Health Holdings, Inc.(NasdaqCM: XAGE) dropped from S&P TMI Index - MarketScreener

Fri, 12 Sep 2025
Longevity Health Faces Nasdaq Delisting Notice - TipRanks

Tue, 15 Jul 2025
XAGE Shares Surge: Should You Dive In? - StocksToTrade

Mon, 14 Jul 2025
Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction - GlobeNewswire

Mon, 14 Jul 2025
Longevity Health to acquire THPlasma in all-stock merger - Investing.com

Mon, 14 Jul 2025
Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	0 (M)
Shares Float	2 (M)
Held by Insiders	1.67e+006 (%)
Held by Institutions	11.3 (%)
Shares Short	25 (K)
Shares Short P.Month	0 (K)

EPS	-5.71e+006
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-369.1 %
Return on Assets (ttm)	-82.8 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	3 %
Gross Profit (p.s.)	2905.29
Sales Per Share	3.08824e+006
EBITDA (p.s.)	1.77768e+006
Qtrly Earnings Growth	-8.7 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-4 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	-0.08

Dividend	0
Forward Dividend	8830
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.